Anabolic Steroids and Exercise in Hemodialysis Patients
1 other identifier
interventional
80
0 countries
N/A
Brief Summary
This is a study to find out whether an exercise program during dialysis or a drug called nandrolone decanoate can increase muscle size and strenght in patients on dialysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2000
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2000
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2004
CompletedFirst Submitted
Initial submission to the registry
November 7, 2005
CompletedFirst Posted
Study publicly available on registry
November 8, 2005
CompletedJanuary 14, 2010
January 1, 2010
November 7, 2005
January 12, 2010
Conditions
Outcome Measures
Primary Outcomes (1)
Primary outcomes included change in lean body mass measured by dual-energy X-ray absorptiometry, quadriceps muscle cross-sectional area (CSA) measured by MRI, and knee extensor muscle strength.
Secondary Outcomes (1)
Secondary outcomes included changes in physical performance, self-reported physical functioning, and physical activity.
Interventions
Eligibility Criteria
You may qualify if:
- end-stage renal disease on hemodialysis for 3 or more months
You may not qualify if:
- inadequate dialysis; Kt/V \<1.2
- nonadherent to dialysis treatments; missing \>2 dialysis sessions in the month prior to screening
- catabolic state; HIV with opportunistic infection in the last 3 months, malignancy, or infection requiring intravenous antibiotics within 2 months prior to screening
- unable to give informed consent
- active intravenous drug use
- contraindications to resistance exercise; myocardial infarction within 6 months, active angina, uncompensated congestive heart failure, orthopedic or musculoskeletal limitations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Natale P, Ju A, Strippoli GF, Craig JC, Saglimbene VM, Unruh ML, Stallone G, Jaure A. Interventions for fatigue in people with kidney failure requiring dialysis. Cochrane Database Syst Rev. 2023 Aug 31;8(8):CD013074. doi: 10.1002/14651858.CD013074.pub2.
PMID: 37651553DERIVEDBernier-Jean A, Beruni NA, Bondonno NP, Williams G, Teixeira-Pinto A, Craig JC, Wong G. Exercise training for adults undergoing maintenance dialysis. Cochrane Database Syst Rev. 2022 Jan 12;1(1):CD014653. doi: 10.1002/14651858.CD014653.
PMID: 35018639DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kirsten L Johansen, MD
University of California, San Francisco, San Francisco VA Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- NIH
Study Record Dates
First Submitted
November 7, 2005
First Posted
November 8, 2005
Study Start
March 1, 2000
Study Completion
October 1, 2004
Last Updated
January 14, 2010
Record last verified: 2010-01